The effect of the inhaled PDE4 inhibitor CHF6001 on allergen-induced inflammation in asthmatics

被引：0
|
作者：
Singh, Dave
Leaker, Brian
Boyce, Malcom
Nandeuil, Marie -Anna
Collarini, Sara
Mariotti, Fabrizia
Santoro, Debora
Barnes, Peter J.
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Anti-inflammatory; COPD; -; management; Pharmacology;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects
    Harbinson, PL
    MacLeod, D
    Hawksworth, R
    OToole, S
    Sullivan, PJ
    Heath, P
    Kilfeather, S
    Page, CP
    Costello, J
    Holgate, ST
    Lee, TH
    EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (05) : 1008 - 1014
  • [32] LATE-BREAKING ABSTRACT: The PDE4 inhibitor CHF-6001 and LAMAs cooperatively inhibit bronchoconstriction-induced remodeling in lung slices
    Kistemaker, Loes E. M.
    Oenema, Tjitske A.
    de Jager, Wim A.
    Bos, I. Sophie T.
    Facchinetti, Fabrizio
    Villetti, Gino
    Gosens, Reinoud
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [33] The effect of inhaled budesonide on baseline and allergen-induced airway inflammatory cells in atopic asthmatics.
    Gauvreau, GM
    Mastruzzo, C
    Watson, RM
    O'Byrne, PM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A632 - A632
  • [34] THE EFFECT OF INHALED VERAPAMIL ON ALLERGEN-INDUCED BRONCHOCONSTRICTION
    PATEL, KR
    ALSHAMA, MR
    KERR, JW
    CLINICAL ALLERGY, 1983, 13 (02): : 119 - 122
  • [35] Pharmacology of a potent and selective inhibitor of PDE4 for inhaled administration
    Chapman, Richard W.
    House, Aileen
    Richard, Jennifer
    Prelusky, Dan
    Lamca, James
    Wang, Peng
    Lundell, Dan
    Wu, Ping
    Ting, Pauline C.
    Lee, Joe F.
    Aslanian, Robert
    Phillips, Jonathan E.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 643 (2-3) : 274 - 281
  • [36] Concentration-QT Modeling Following Inhalation of the Novel Inhaled Phosphodiesterase-4 Inhibitor CHF6001 in Healthy Volunteers Shows an Absence of QT Prolongation
    Jolling, Koen
    Abelo, Angela
    Luyckx, Nicolas
    Nandeuil, Marie-Anna
    Govoni, Mirco
    Cella, Massimo
    Lindauer, Andreas
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (07): : 460 - 468
  • [37] Effect of formoterol on allergen-induced cytokine synthesis by atopic asthmatics
    Hashimoto, Tomomi
    Kitamura, Noriko
    Kobayashi, Noriaki
    Suko, Matsunobu
    Kaminuma, Osamu
    Mori, Akio
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2007, 143 : 106 - 109
  • [38] EFFECT OF ORAL AND INHALED CETIRIZINE IN ALLERGEN-INDUCED BRONCHOCONSTRICTION
    RAFFERTY, P
    GHOSH, SK
    DEVOS, C
    PATEL, KR
    CLINICAL AND EXPERIMENTAL ALLERGY, 1993, 23 (06): : 528 - 531
  • [39] Duration of protection by inhaled budesonide on allergen-induced airway responses in atopic asthmatics.
    Gauvreau, GM
    Wood, LJ
    Watson, RM
    O'Byrne, PM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A632 - A632
  • [40] Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers
    Mariotti, Fabrizia
    Govoni, Mirco
    Lucci, Germano
    Santoro, Debora
    Nandeuil, Marie Anna
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 3399 - 3410
12345